News
-
-
COMMUNIQUÉ DE PRESSE
3U HOLDING AG: sound development of business in the first half of 2025 despite a challenging environment
3U HOLDING AG reports sound business development in the first half of 2025 despite challenges, affirms outlook. Strategic realignment in HVAC segment and extended Bitcoin investment -
-
COMMUNIQUÉ DE PRESSE
Relief Therapeutics Publishes 2025 Half-Year Report
Relief Therapeutics published its 2025 half-year report, highlighting progress in pipeline candidates for rare diseases and financial status. Corporate update includes advances in wound care and liquid formulation for phenylketonuria -
COMMUNIQUÉ DE PRESSE
Wacker Neuson Group publishes Half-year Report and confirms the guidance for the financial year 2025
Wacker Neuson Group publishes Half-year Report for H1/2025, confirming guidance for 2025. Revenue at EUR 1,074.9 million, EBIT margin at 5.2%. Free cash flow positive at EUR 67.7 million -
COMMUNIQUÉ DE PRESSE
Brockhaus Technologies AG: Revenue rises in H1 2025 by +2.6% to €112 million with adjusted EBITDA of €25 million – 2025 outlook confirmed
Brockhaus Technologies AG reports +2.6% revenue growth in H1 2025 to €112 million, adjusted EBITDA at €25 million, confirmed outlook for 2025 -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4
Sanofi obtient la désignation de médicament orphelin pour le rilzabrutinib dans l'UE contre la maladie liée aux IgG4. Étude de phase 2 positive présentée à l'EULAR 2025 -
-
-
